Preclinical Drug Efficacy Research Services

Contract Research Organisation, Pharmatest provides complete Preclinical Drug Efficacy Research Services. For the fields of cancer and skeletal diseases, Pharmatest offers a wide range of efficacy models, from in vitro cell culture assays to in vivo models.

In line with the FDA’s and EMEA’s regulatory guidelines, Pharmatest has developed specific study setups for testing new drug candidates. Specifically designed studies are also available for testing biosimilars and functional foods that have fewer regulatory requirements. A range of Pharmatest’s models meet the requirements of the new EU-regulatory framework REACH and are therefore suitable for safety testing of chemicals.

Pharmatest is dedicated to high clinical predictivity. All of our research models have been subject to many years of extensive research and have been developed to ensure clinical predictivity. In addition, through the attention paid by R&D on the development of more predictive cell cultures, Pharmatest is committed to reducing clients’ costs and the need for animal testing.

Pharmatest’s internal Quality Assurance System and Standard Operating Procedures ensure the quality of work carried out. Significantly lower efficacy-related failure rates in later stages of drug development are achieved through the use of the organisation’s quality Preclinical Drug Efficacy Research Services.

For more information or to discuss preclinical drug efficacy research services please contact us directly.